APA (7th ed.) Citation

Koram, K. A., Adu, B., Ocran, J., Karikari, Y. S., Adu-Amankwah, S., Ntiri, M., . . . Nkrumah, F. (2016). Safety and Immunogenicity of EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly in Semi-Immune Adults: A Phase 1, Double-Blinded Placebo Controlled Dosage Escalation Study. PloS one, 11(9), e0163066. https://doi.org/10.1371/journal.pone.0163066

Chicago Style (17th ed.) Citation

Koram, Kwadwo A., et al. "Safety and Immunogenicity of EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly in Semi-Immune Adults: A Phase 1, Double-Blinded Placebo Controlled Dosage Escalation Study." PloS One 11, no. 9 (2016): e0163066. https://doi.org/10.1371/journal.pone.0163066.

MLA (9th ed.) Citation

Koram, Kwadwo A., et al. "Safety and Immunogenicity of EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly in Semi-Immune Adults: A Phase 1, Double-Blinded Placebo Controlled Dosage Escalation Study." PloS One, vol. 11, no. 9, 2016, p. e0163066, https://doi.org/10.1371/journal.pone.0163066.